at Benzinga.com (Jan 13, 2015)
Amarin (AMRN +1.85%) says the Patent Office has published a notification of a Notice of Allowance for an application to widen the company's patent claims to include the use of its heart pill Vascepa with and without other lipid lowering agents, such as statins. A Notice of Allowance means the USPTO has decided that a patent can be granted from an application.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Nov 19, 2014)
at CNBC.com (Feb 28, 2014)
at MarketWatch.com (Jan 21, 2014)
at CNBC.com (Oct 17, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs